Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (NASDAQ:PODD – Get Rating) had its price target cut by stock analysts at Morgan Stanley from $268.00 to $244.00 in a report released on Tuesday, Stock Target Advisor reports. The brokerage presently has an “equal weight” rating on the medical instruments supplier’s stock. Morgan Stanley’s target price would indicate a potential upside of 12.05% […]
Equities analysts expect Insulet Co. (NASDAQ:PODD – Get Rating) to report $0.22 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Insulet’s earnings, with the lowest EPS estimate coming in at $0.13 and the highest estimate coming in at $0.39. Insulet reported earnings of $0.10 per […]
Equities research analysts forecast that Insulet Co. (NASDAQ:PODD – Get Rating) will post earnings per share (EPS) of $0.22 for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Insulet’s earnings, with estimates ranging from $0.13 to $0.39. Insulet posted earnings per share of $0.10 in the same quarter last year, […]
Insulet (NASDAQ:PODD – Get Rating) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.17, MarketWatch Earnings reports. The firm had revenue of $295.40 million during the quarter, compared to the consensus estimate of $287.99 million. Insulet had a net […]
Insulet (NASDAQ:PODD – Get Rating) had its price target decreased by Wells Fargo & Company from $357.00 to $345.00 in a research note issued to investors on Friday, The Fly reports. Wells Fargo & Company‘s target price indicates a potential upside of 52.04% from the stock’s previous close. PODD has been the topic of several […]